Do intronic mutations affecting splicing of WT1 exon 9 cause Frasier syndrome?

Haruhito Kikuchi, Ayako Takata, Yoshikiyo Akasaka, Ryuji Fukuzawa, Hiroshi Yoneyama, Yoshihiro Kurosawa, Masataka Honda, Yasunori Kamiyama, Jun Ichi Hata

研究成果: Article査読

79 被引用数 (Scopus)


The WT1 gene, one of the genes responsible for Wilms tumour, is thought to play a crucial role in the development of the kidneys and gonads. This gene encodes four protein isoforms resulting from two alternative splicing sites, one of which involves inclusion or exclusion of lysine, threonine, and serine (KTS) between the third and fourth zinc finger domains. WT1 is virtually always mutationally inactivated in patients with Denys-Drash syndrome. We analysed WT1 in eight patients who had been diagnosed as having this syndrome, and identified five previously unknown mutations affecting splicing donor sites of intron 9. These mutations affect alternative splicing. The isoforms retaining KTS are not produced. The clinical features of the patients with these intronic mutations were consistent with those of Frasier syndrome, characterised by a more slowly progressive nephropathy than Denys-Drash syndrome, associated streak gonads, and no Wilms tumour development. Our results indicate that WT1 isoforms, including/excluding KTS, have different functions in tumorigenesis and organogenesis of the kidneys and gonads.

ジャーナルJournal of medical genetics
出版ステータスPublished - 1998

ASJC Scopus subject areas

  • 遺伝学
  • 遺伝学(臨床)


「Do intronic mutations affecting splicing of WT1 exon 9 cause Frasier syndrome?」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。